Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Trubiano

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Immunology and Allergy Clinics of North America|April 26, 2022
A Risk-Based Approach to Penicillin AllergyJason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2021
New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug ReactionsJason A Trubiano
The Australasian Journal of Dermatology|January 18, 2023
Time to reinvent the wheel for drug causality diagnostic approaches to severe cutaneous adverse reactionsAndrew Awad, Jason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|June 11, 2021
Delayed hypersensitivity reactions to piperacillin-tazobactamAna Copaescu, Jason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2022
New Clinical Insights Into Pediatric DRESS to Tailor Future Care?Andrew Awad, Jason A Trubiano
Australian Prescriber|January 16, 2020
Penicillin allergy: a practical approach to assessment and prescribingMisha Devchand, Jason A Trubiano
Sexual Health|December 22, 2014
Taming the great: enhanced syphilis screening in HIV-positive men who have sex with men in a hospital clinic settingJason A Trubiano, Jennifer F Hoy
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2025
Spot On? Moving Forward IFN-γ ELISpot as a Causality Tool for Severe Delayed Hypersensitivity Reactions in Persons Living With HIVTukisa D Smith, Jason A Trubiano
The Journal of Allergy and Clinical Immunology|April 5, 2023
In vitro/ex vivo assays for severe cutaneous drug reactionsAna Maria Copaescu, Jason A Trubiano
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Antibiotic allergy labels in immunocompromised populationsJamie L Waldron, Jason A Trubiano
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Immunology and Allergy Clinics of North America|April 26, 2022
A Risk-Based Approach to Penicillin AllergyJason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|September 11, 2021
New Pathways to Navigate an Old Problem of Tuberculosis Therapy-Associated Adverse Drug ReactionsJason A Trubiano
The Australasian Journal of Dermatology|January 18, 2023
Time to reinvent the wheel for drug causality diagnostic approaches to severe cutaneous adverse reactionsAndrew Awad, Jason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|June 11, 2021
Delayed hypersensitivity reactions to piperacillin-tazobactamAna Copaescu, Jason A Trubiano
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2022
New Clinical Insights Into Pediatric DRESS to Tailor Future Care?Andrew Awad, Jason A Trubiano
Australian Prescriber|January 16, 2020
Penicillin allergy: a practical approach to assessment and prescribingMisha Devchand, Jason A Trubiano
Sexual Health|December 22, 2014
Taming the great: enhanced syphilis screening in HIV-positive men who have sex with men in a hospital clinic settingJason A Trubiano, Jennifer F Hoy
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2025
Spot On? Moving Forward IFN-γ ELISpot as a Causality Tool for Severe Delayed Hypersensitivity Reactions in Persons Living With HIVTukisa D Smith, Jason A Trubiano
The Journal of Allergy and Clinical Immunology|April 5, 2023
In vitro/ex vivo assays for severe cutaneous drug reactionsAna Maria Copaescu, Jason A Trubiano
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Antibiotic allergy labels in immunocompromised populationsJamie L Waldron, Jason A Trubiano
Pageof 21